Search hospitals > Michigan > Detroit
Josephine Ford Cancer Center at Henry Ford Hospital
Claim this profileDetroit, Michigan 48202
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Brain Tumor
Conducts research for Central Nervous System Tumor
Conducts research for Glioblastoma
175 reported clinical trials
9 medical researchers
Summary
Josephine Ford Cancer Center at Henry Ford Hospital is a medical facility located in Detroit, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Brain Tumor, Central Nervous System Tumor, Glioblastoma and other specialties. Josephine Ford Cancer Center at Henry Ford Hospital is involved with conducting 175 clinical trials across 203 conditions. There are 9 research doctors associated with this hospital, such as Ding Wang, Shirish Gadgeel, MD, Tobias Walbert, MD, PhD, MPH, and Philip Kuriakose, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
Ding WangHenry Ford Hospital6 years of reported clinical research
Expert in Lung Cancer
Studies Cancer
47 reported clinical trials
104 drugs studied
Shirish Gadgeel, MDHenry Ford Hospital4 years of reported clinical research
Expert in Lung Cancer
Studies Solid Tumors
19 reported clinical trials
30 drugs studied
Tobias Walbert, MD, PhD, MPHHenry Ford Hospital7 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
12 reported clinical trials
17 drugs studied
Philip Kuriakose, MDHenry Ford Health System5 years of reported clinical research
Studies Hemophilia
Studies Hemophilia A
11 reported clinical trials
20 drugs studied
Clinical Trials running at Josephine Ford Cancer Center at Henry Ford Hospital
Breast Cancer
Lung Cancer
Cancer
Acute Myeloid Leukemia
Leukemia
Acute Myelogenous Leukemia
Solid Tumors
Non-Small Cell Lung Cancer
Metastatic Tumor
Pancreatic Cancer
Endoxifen
for Breast Cancer
This trial is testing (Z)-endoxifen, a drug that blocks estrogen, in pre-menopausal women with a specific type of breast cancer. The study aims to see if this drug can slow down cancer growth by measuring a marker called Ki-67. Participants will take the drug daily for several months before surgery.
Recruiting1 award Phase 27 criteria
IAM1363
for Breast Cancer
This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 in participants with advanced cancers that harbor HER2 alterations.
Recruiting1 award Phase 1
MRT-2359
for Solid Tumors
This trial tests a new drug called MRT-2359 that breaks down a protein in cancer cells. It targets patients with certain types of previously treated cancers. The drug aims to destroy a protein crucial for cancer cell survival, potentially stopping or slowing the cancer.
Recruiting1 award Phase 1 & 27 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Josephine Ford Cancer Center at Henry Ford Hospital?
Josephine Ford Cancer Center at Henry Ford Hospital is a medical facility located in Detroit, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Brain Tumor, Central Nervous System Tumor, Glioblastoma and other specialties. Josephine Ford Cancer Center at Henry Ford Hospital is involved with conducting 175 clinical trials across 203 conditions. There are 9 research doctors associated with this hospital, such as Ding Wang, Shirish Gadgeel, MD, Tobias Walbert, MD, PhD, MPH, and Philip Kuriakose, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.